The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
NCT05988385
This study is recruiting at 4 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
The Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) study is a 5-year, multicenter randomized open-label trial that will screen 400 cognitively normal older adults recruited from well-established sleep clinics at 4 academic medical centers, with newly diagnosed moderate-severe OSA.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Obstructive Sleep Apnea
- Cognitive Decline
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 55 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- California Pacific Medical Center Research Institute
- Last updated on ClinicalTrials.gov
- August 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- University of Arizona · Tucson, AZ
New York · 2
- Mount Sinai · New York, NY
- New York University · New York, NY
Pennsylvania · 1
- University of Pittsburgh · Pittsburgh, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.